Ultrasonic attenuation in human calcaneus from 0.2 to 1.7 MHz.
Ultrasonic attenuation has been demonstrated to be a useful measurement in the diagnosis of osteoporosis. Most studies have employed ultrasound in a range of frequencies from about 200 kHz-300 kHz to 600 kHz-1 MHz, and many have assumed a linear dependence of attenuation on frequency. In order to investigate the attenuation properties of human calcaneus at higher frequencies, 16 defatted human calcanea were interrogated in vitro using two matched pairs of transducers with center frequencies of 500 kHz and 2.25 MHz. The linear dependence of attenuation on frequency seems to extend up to at least 1.7 MHz. The correlation between attenuation coefficient and frequency from 400 kHz to 1.7 MHz was r = 0.999 (95% confidence interval, CI, = 0.998-1.00). The measurements suggest that some deviations from linear frequency dependence of attenuation may occur at lower frequencies (below 400 kHz), however.
Wear
K A
KA
U.S. Food and Drug Administration, Center for Devices and Radiological Health, HFZ-142, Rockville, MD 20852, USA. kaw@cdrh.fda.gov
D001698:Biomedical Engineering; D002111:Calcaneus / Q000000981:diagnostic imaging*; D006801:Humans; D066298:In Vitro Techniques; D010024:Osteoporosis / Q000175:diagnosis*; D019047:Phantoms, Imaging; D014159:Transducers; D014463:Ultrasonography / Q000295:instrumentation / Q000379:methods